Cargando…

Imaging modalities for drug-related osteonecrosis of the jaw (3), Positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw()

Medication-related osteonecrosis of jaws (MRONJ) is one of the most complicated inflammatory conditions in oral and maxillofacial region. It is very difficult to correctly evaluate the degree and extent of necrosis and infection. This refractory osteonecrosis often needs extended surgery, leading to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitagawa, Yoshimasa, Ohga, Noritaka, Asaka, Takuya, Sato, Jun, Hata, Hironobu, Helman, Joseph, Tsuboi, Kanako, Amizuka, Norio, Kuge, Yuji, Shiga, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430078/
https://www.ncbi.nlm.nih.gov/pubmed/30949253
http://dx.doi.org/10.1016/j.jdsr.2018.12.001
_version_ 1783405725652877312
author Kitagawa, Yoshimasa
Ohga, Noritaka
Asaka, Takuya
Sato, Jun
Hata, Hironobu
Helman, Joseph
Tsuboi, Kanako
Amizuka, Norio
Kuge, Yuji
Shiga, Tohru
author_facet Kitagawa, Yoshimasa
Ohga, Noritaka
Asaka, Takuya
Sato, Jun
Hata, Hironobu
Helman, Joseph
Tsuboi, Kanako
Amizuka, Norio
Kuge, Yuji
Shiga, Tohru
author_sort Kitagawa, Yoshimasa
collection PubMed
description Medication-related osteonecrosis of jaws (MRONJ) is one of the most complicated inflammatory conditions in oral and maxillofacial region. It is very difficult to correctly evaluate the degree and extent of necrosis and infection. This refractory osteonecrosis often needs extended surgery, leading to impaired quality-of-life. We have performed hyperbaric oxygen therapy (HBO) combined with conservative surgery for advanced cases. We have appraised the value of FDG-PET and 3-phase bone scintigraphy in the diagnosis and management of this condition. MRONJ showed significantly higher SUV(max) on FDG-PET than the others. Although the 3 phase pool bone images did not change significantly, perfusion and static bone image as well as PET showed remarkable response to HBO for MRONJ. SUV(max) after HBO was significantly lower than those of before HBO. These preliminary results indicate that FDG-PET is useful for monitoring the effect of HBO for MRONJ.
format Online
Article
Text
id pubmed-6430078
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-64300782019-04-04 Imaging modalities for drug-related osteonecrosis of the jaw (3), Positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw() Kitagawa, Yoshimasa Ohga, Noritaka Asaka, Takuya Sato, Jun Hata, Hironobu Helman, Joseph Tsuboi, Kanako Amizuka, Norio Kuge, Yuji Shiga, Tohru Jpn Dent Sci Rev Article Medication-related osteonecrosis of jaws (MRONJ) is one of the most complicated inflammatory conditions in oral and maxillofacial region. It is very difficult to correctly evaluate the degree and extent of necrosis and infection. This refractory osteonecrosis often needs extended surgery, leading to impaired quality-of-life. We have performed hyperbaric oxygen therapy (HBO) combined with conservative surgery for advanced cases. We have appraised the value of FDG-PET and 3-phase bone scintigraphy in the diagnosis and management of this condition. MRONJ showed significantly higher SUV(max) on FDG-PET than the others. Although the 3 phase pool bone images did not change significantly, perfusion and static bone image as well as PET showed remarkable response to HBO for MRONJ. SUV(max) after HBO was significantly lower than those of before HBO. These preliminary results indicate that FDG-PET is useful for monitoring the effect of HBO for MRONJ. Elsevier 2019-11 2019-03-15 /pmc/articles/PMC6430078/ /pubmed/30949253 http://dx.doi.org/10.1016/j.jdsr.2018.12.001 Text en © 2019 Published by Elsevier Ltd on behalf of The Japanese Association for Dental Science. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Kitagawa, Yoshimasa
Ohga, Noritaka
Asaka, Takuya
Sato, Jun
Hata, Hironobu
Helman, Joseph
Tsuboi, Kanako
Amizuka, Norio
Kuge, Yuji
Shiga, Tohru
Imaging modalities for drug-related osteonecrosis of the jaw (3), Positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw()
title Imaging modalities for drug-related osteonecrosis of the jaw (3), Positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw()
title_full Imaging modalities for drug-related osteonecrosis of the jaw (3), Positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw()
title_fullStr Imaging modalities for drug-related osteonecrosis of the jaw (3), Positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw()
title_full_unstemmed Imaging modalities for drug-related osteonecrosis of the jaw (3), Positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw()
title_short Imaging modalities for drug-related osteonecrosis of the jaw (3), Positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw()
title_sort imaging modalities for drug-related osteonecrosis of the jaw (3), positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430078/
https://www.ncbi.nlm.nih.gov/pubmed/30949253
http://dx.doi.org/10.1016/j.jdsr.2018.12.001
work_keys_str_mv AT kitagawayoshimasa imagingmodalitiesfordrugrelatedosteonecrosisofthejaw3positronemissiontomographyimagingforthediagnosisofmedicationrelatedosteonecrosisofthejaw
AT ohganoritaka imagingmodalitiesfordrugrelatedosteonecrosisofthejaw3positronemissiontomographyimagingforthediagnosisofmedicationrelatedosteonecrosisofthejaw
AT asakatakuya imagingmodalitiesfordrugrelatedosteonecrosisofthejaw3positronemissiontomographyimagingforthediagnosisofmedicationrelatedosteonecrosisofthejaw
AT satojun imagingmodalitiesfordrugrelatedosteonecrosisofthejaw3positronemissiontomographyimagingforthediagnosisofmedicationrelatedosteonecrosisofthejaw
AT hatahironobu imagingmodalitiesfordrugrelatedosteonecrosisofthejaw3positronemissiontomographyimagingforthediagnosisofmedicationrelatedosteonecrosisofthejaw
AT helmanjoseph imagingmodalitiesfordrugrelatedosteonecrosisofthejaw3positronemissiontomographyimagingforthediagnosisofmedicationrelatedosteonecrosisofthejaw
AT tsuboikanako imagingmodalitiesfordrugrelatedosteonecrosisofthejaw3positronemissiontomographyimagingforthediagnosisofmedicationrelatedosteonecrosisofthejaw
AT amizukanorio imagingmodalitiesfordrugrelatedosteonecrosisofthejaw3positronemissiontomographyimagingforthediagnosisofmedicationrelatedosteonecrosisofthejaw
AT kugeyuji imagingmodalitiesfordrugrelatedosteonecrosisofthejaw3positronemissiontomographyimagingforthediagnosisofmedicationrelatedosteonecrosisofthejaw
AT shigatohru imagingmodalitiesfordrugrelatedosteonecrosisofthejaw3positronemissiontomographyimagingforthediagnosisofmedicationrelatedosteonecrosisofthejaw